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Sir, 
Boelsterli and Zbinden (1985) reported in this journal on 
biochemical and morphological changes of  the rat adrenal 
medulla induced by xylitol. This paper was interesting, 
multifaceted and it elucidated an important biomedical is- 
sue related to xylitol which is becoming a leading nutritive 
sucrose substitute by virtue of  its noncariogenicity and an- 
ticariogenicity, and its suitability in the diabetic diet. Al- 
though the methodology and the presentation of data of  
the above paper were by and large impeccable, we oppose 
the authors' view, presented in their Discussion, that per- 
oral administration of xylitol would cause hyperinsulinem- 
ia and hypoglycemia. Our perusal of  the study of Boelsterli 
and Zbinden showed that some of the data presented does 
not justify the conclusions made. Our view is based on the 
following methodological features and conclusions of their 
study. 
Hyperinsulinemia-hypoglycemia. Peroral administration of 
xylitol does not induce any significant hyperinsulinemia 
and hypoglycemia. This has been convincingly demon- 
strated by several research teams who have studied either 
humans (Muller-Hess et al. 1975; Huttunen 1976; F6rster 
and Mehnert 1981) or experimental animals (Salminen et 
al. 1982; H~im~il~iinen and M~ikinen 1982). The xylitol re- 
port of the Federation of American Societies for Experi- 
mental Biology (1978) came to the same conclusion. Boel- 
sterli and Zbinden sought support for their conclusions 
from the studies of Kosaka (1969), Montaque and Taylor 
(1968) and Asano et al. (1977). However, Kosaka adminis- 
tered xylitol intravenously to rats and Montaque and Tay- 
lor obtained their results from in vitro studies using pan- 
creas cells. Asano et al. used an intravenous infusion tech- 
nique to administer xylitol to fasting dogs. In contrast to 
these procedures, Boelsterli and Zbinden gave xylitol to 
the rats enterally, the method which we have used in rat 
experiments as the only (physiological) route of adminis- 
tration. We have repeatedly emphasized the importance in 
making a clear distinction between enteral and parenteral 
administration techniques, or between enteral feeding and 
any procedure which bypasses the only physiological way 
of administration (M/ikinen 1978; H~im~il~iinen and 
M~ikinen 1981). In a peroral feeding study, slowly ab- 
sorbed carbohydrates like xylitol cannot be expected to 
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produce changes equal to those occasionally associated 
with other type of studies. 
The blood glucose assay method (a test strip) used by 
Boelsterli and Zbinden may not be sufficiently accurate to 
justify the conclusion that hypoglycemia was present. 
Their paper did not mention whether or not the rats were 
in a fed state or not at the termination of the xylitol treat- 
ments. Furthermore, Table 4 in their article shows large 
differences for blood glucose levels in the control animals 
between the 2- and 8-week stages. Our rat experiments, as 
well as those of most other authors, have shown that the 
consumption of xylitol is associated with a slight decrease 
in blood glucose levels, but all values have been within the 
normal physiological range. This is evidenced by the nor- 
mal serum glucagon levels, for example, of xylitol-fed 
rats; increased glucagon could be regarded as a primary 
indicator of hypoglycemia. 
Decrease of  the synthesis of  catecholamines. We think that 
the decrease in the rate of  the synthesis of  catecholamines 
reported by Boelsterli and Zbinden (1985) was not convin- 
cingly demonstrated. These authors showed only marginal 
differences in the conversion of radioactively labelled ty- 
rosine into catecholamines. The determination of the activ- 
ities of  tyrosine hydroxylase, dopamine-13-hydroxylase and 
phenylethanolamine-N-methyltransferase also revealed 
only slight differences between the control animals and 
those fed xylitol. In the case of  catecholamines, the small 
differences between the control diet and the xylitol diet 
can be examined in the light of  the extremely low CPM va- 
lues (which we regard as falling in the borderline of reli- 
able measurements), and the small number (four to five) of  
animals tested. In fact, the conversion of labelled tyrosine 
into catecholamines in the xylitolfed rats was lower in one 
case only: A decrease in the synthesis of  [14C]-dopamine 
was reported in rats given 20% xylitol in food. However, in 
this comparison p<0.02 and the number of  animals was 
four to five. In this case Boelsterli and Zbinden gave the 
animals 25 ktCi [t4C]-tyrosine (5.5 x 10  7 DPM) and found 
only about 130-200 DPM in the form of dopamine. Con- 
sequently, we would like to question the capacity of the 
analytical high-performance liquid chromatographic tech- 
nique used in the fractionation of all the catecholamines 
from both glands. The procedures presented in the papers 
involved (Boelsterli et al. 1984; Boelsterli and Zbinden 
1985) did not provide enough details for us to judge the 
validity of these methods. Taking into account the contam- 
inat ion risks and the relat ively complex puri f icat ion proce-  
dure of  catecholamines,  these da ta  seems to be random.  It 
is necessary to point  out that  the authors themselves 
showed that  the chemically determined ca techolamine va- 
lues were almost  identical  in all exper imental  groups. 
Volume of the chromaffin cells. The volumes (V) of  the 
chromaff in  cells o f  the adrenal  medul la  repor ted  by Boel- 
sterli and Zbinden  (1985) do not  follow the logical age or- 
der  of  the animals ,  because V was smaller  (0.472 mm 3) in 
the 14-week-old rats than in the 8-week-old rats 
(0.517 mm3). In  contrast  to their present  findings,  Boelster- 
li and  Zbinden  (Boelsterli  et al. 1984) have previously de- 
mons t ra ted  an increase in V as a function of  age (7 weeks, 
0.420 mm3; 12 weeks, 0.643 mm3). In both cases the values 
presented were from untrea ted  control  rats. Consequent ly ,  
the repor ted  increase in the total  volume of  the adrenal  
medul la  of  rats fed xylitol in the later s tudy o f  these au- 
thors (Boelsterli  and  Zbinden  1985) may be an artefact  re- 
sulting from labile exper imenta l  arrangements .  
Based on the above considerat ions ,  our view is that the pa- 
per  of  Boelsterli and  Zbinden  (1985) does not reveal any 
significant changes taking place in the metabol ism of  the 
rat  adrenal  medul la  of  rats fed xylitol. We have reached a 
s imilar  conclusion on the basis of  our  rat  studies 
(H/im/il~iinen and M/ikinen 1986). 
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